Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05833659

Comparison Between Prepectoral and Subpectoral Breast Reconstruction

There are controversies about breast implant-based reconstruction techniques. Our center pioneered single-port insufflation endoscopic nipple-sparing mastectomy (SIE-NSM) combined with stage I prosthesis reconstruction. The study's primary objective is to compare single-port endoscopic NSM combined with pre-pectoral breast reconstruction to the subpectoral breast reconstruction group regarding breast satisfaction.

This study is an ambispective cohort study. The study will be conducted at Beijing Friendship Hospital, affiliated with Capital Medical University. Patients will be enrolled retrospectively from January 2014 to March 2022 by reviewing the medical records and recruited prospectively from March 2022 to March 2025. The two cohorts are the pre-pectoral breast reconstruction cohort and the subpectoral breast reconstruction cohort, both following single-port insufflation endoscopic nipple-sparing mastectomy. The primary outcome of this study is postoperative breast satisfaction, which the BREAST-Q score will measure. The different variables will be compared using the Χ2 test for categorical variables and the Mann-Whitney test for continuous variables.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–70 year

Sex eligibility

Female

Study type

Observational

Primary location

Beijing Friendship Hospital, Capital medical University

Beijing, Beijing Municipality, China

Location status: Recruiting

Location contact

guoxuan Guo

CONTACT

[email protected]

+861063138712

About this study

Sample size and statistical analysis This study is an ambispective cohort study. According to the previous retrospective research data of the center, the breast satisfaction score is the main research object. The standard deviation was 2.6, the non-inferiority margin was 0.15, the test level was α=0.05, β=0.2, and a one-sided test was performed. Eighty patients will be needed for two cohorts in a 1:1 ratio. Considering the 10% loss to follow-up rate, 44 patients will be required to be enrolled in each group.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female patients with preoperative pathologically confirmed early-stage invasive breast cancer (stage I or stage II) by core needle biopsy.
  • Breast-conserving surgery is not possible due to the presence of contraindications to breast-conserving surgery, or the patient actively requests total mastectomy.
  • Patients having willingness for breast reconstruction.
  • Age between 18 to 70 years.
  • Maximum diameter of the cancer lesion ≤ 3 cm.
  • Physical examination and breast magnetic resonance imaging (MRI) confirmed that the tumor did not invade the skin, subcutaneous tissue, or chest wall.
  • The distance between the lesion and the nipple is ≥2 cm, and it is confirmed by physical examination and MRI that the nipple-areola complex is not invaded.
  • Eastern Cooperative Oncology Group (ECOG) Performance Status Scale of 0 to 2.

Exclusion criteria

  • patients having serious medical diseases, including unstable angina pectoris, myocardial infarction, and cerebrovascular accident within 6 months.
  • Having history of malignant tumor (s) within 5 years.
  • Patients under immunosuppressive therapy for organ transplantation.
  • Having continuous systemic steroid hormone therapy.
  • Pregnant or lactating women.

Treatment and study plan

The breast reconstruction method after single-port insufflation endoscopic nipple-sparing mastectomy

Procedure

Group A:The prepectoral breast reconstruction. Group B:The subpectoral breast reconstruction

Primary outcomes

  1. breast satisfaction

    Time frame: 12 months after operation

    measured by BREAST-Q score

Secondary outcomes

  1. Physical well-being of chest

    Time frame: 12 months after operation

    measured by BREAST-Q score

  2. Animation deformity

    Time frame: 12 months after operation

    confirmed by the doctor's physical examination

  3. Adverse events

    Time frame: within 30 days after surgery

    according to Clavien-Dindo system

  4. Local recurrence and distant metastasis of breast cancer

    Time frame: 12 months after operation

    physical examination or imaging examination with histologically confirmed

Study contacts

Contact information is provided by the study sponsor or research team.

guoxuan gao, MD

CONTACT

[email protected]

+861063138712

Sponsors and collaborators

Lead sponsor

Beijing Friendship Hospital

Other

Collaborators

  • Beijing Health Promotion Association

Registry information

Official study title

The Comparison Between Prepectoral Breast Reconstruction and Subpectoral Breast Reconstruction Following Single-port Insufflation Endoscopic Nipple-sparing Mastectomy

Acronym: RESPECT

Important dates

Study start
2022
Primary completion
2025
Study completion
2027
First posted
Apr 27, 2023
Registry last updated
Apr 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.